iCo Therapeutics Announces Changes to Board of Directors
December 24, 2015, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:
December 24, 2015, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:
November 24, 2015, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)
October 26, 2015, Vancouver, Canada – iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:
August 26, 2015, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)
June 26, 2015, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)
May 28, 2015, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)
April 27, 2015, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)